John Burns
Director of Finance/CFO at SELLAS LIFE SCIENCES GROUP, INC.
Net worth: 141 995 $ as of 30/04/2024
John Burns active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Comptroller/Controller/Auditor | 30/12/2017 | - |
| Director of Finance/CFO | 30/12/2017 | - |
Career history of John Burns
Former positions of John Burns
| Companies | Position | Start | End |
|---|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 23/02/2016 | - |
Training of John Burns
| Tulane University (Louisiana) | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Stock Market
- Insiders
- John Burns
- Experience